FAM
PDSB icon

Fred Alger Management’s PDS Biotechnology PDSB Stock Holding History

Fred Alger Management’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-119,082
Closed -$737K – 539
2022
Q1 		$737K Hold
119,082
– – ﹤0.01% 407
2021
Q4 		$965K Hold
119,082
– – ﹤0.01% 406
2021
Q3 		$1.77M Buy
+119,082
New +$1.48M ﹤0.01% 353

Other funds holding PDSB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Fred Alger Management's PDSB Position: Q2 2022 in Review

Fred Alger Management sold out of PDS Biotechnology (PDSB) in Q2 2022, closing a stake of 119,082 shares — an estimated $737K sold.

Fred Alger Management first reported a position in PDSB in Q3 2021 and held it in 3 quarters. The position peaked at $1.77M in Q3 2021. 51 funds tracked by Wall St. Rank hold PDSB as of Q2 2022.

  • Fred Alger Management reported no remaining PDS Biotechnology position as of Q2 2022 after selling out during the quarter.
  • Fred Alger Management sold 119,082 PDS Biotechnology shares in Q2 2022, an estimated $737K.
  • Fred Alger Management first reported a position in PDS Biotechnology in Q3 2021 and held it in 3 quarters.
  • Fred Alger Management's PDS Biotechnology position peaked at $1.77M in Q3 2021.
  • 51 funds tracked by Wall St. Rank held PDS Biotechnology as of Q2 2022.

Based on Fred Alger Management's 13F filing for Q2 2022, filed 15 Aug 2022.